Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of Ga-68-Tris (Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer
Michael S Hofman, Peter Eu, Price Jackson, Emily Hong, David Binns, Amir Iravani, Declan Murphy, Catherine Mitchell, Shankar Siva, Rodney J Hicks, Jennifer D Young, Philip J Blower, Gregory E Mullen
Journal of Nuclear Medicine | SOC NUCLEAR MEDICINE INC | Published : 2018
Awarded by Imperial College London EPSRC Centre for Doctoral Training in Medical Imaging
Awarded by Engineering and Physical Sciences Research Council
The study received funding from Theragnostics Ltd. Philip J. Blower and Gregory E. Mullen are named inventors on patents whose claims encompass the THP chelator. Jennifer D. Young is funded by the King's College London and Imperial College London EPSRC Centre for Doctoral Training in Medical Imaging (EP/L015226/1). We acknowledge support from the KCL and UCL Comprehensive Cancer Imaging Centre funded by CRUK and EPSRC in association with the MRC and DoH (England) and support from the NIRH Biomedical Research Centre awarded to the Guy's and St. Thomas' NHS Foundation Trust in partnership with the King's College London and King's College Hospital NHS Foundation Trust. No other potential conflict of interest relevant to this article was reported.